NEI
BNR

Northwest & Ethical Investments’s Burning Rock Biotech BNR Stock Holding History

Northwest & Ethical Investments’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,060
Closed -$196K – 409
2021
Q4 		$196K Sell
2,060
-7,064
-77% -$968K 0.01% 380
2021
Q3 		$1.63M Buy
9,124
+732
+9% +$163K 0.05% 245
2021
Q2 		$2.47M Buy
8,392
+2,858
+52% +$846K 0.08% 223
2021
Q1 		$1.49M Buy
5,534
+1,551
+39% +$472K 0.05% 299
2020
Q4 		$920K Hold
3,983
– – 0.04% 332
2020
Q3 		$999K Buy
3,983
+704
+21% +$167K 0.04% 310
2020
Q2 		$886K Buy
+3,279
New +$899K 0.04% 312

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northwest & Ethical Investments's BNR Position: Q1 2022 in Review

Northwest & Ethical Investments sold out of Burning Rock Biotech (BNR) in Q1 2022, closing a stake of 2,060 shares — an estimated $196K sold.

Northwest & Ethical Investments first reported a position in BNR in Q2 2020 and held it in 7 quarters. The position peaked at $2.47M in Q2 2021. 46 funds tracked by Wall St. Rank hold BNR as of Q1 2022.

  • Northwest & Ethical Investments reported no remaining Burning Rock Biotech position as of Q1 2022 after selling out during the quarter.
  • Northwest & Ethical Investments sold 2,060 Burning Rock Biotech shares in Q1 2022, an estimated $196K.
  • Northwest & Ethical Investments first reported a position in Burning Rock Biotech in Q2 2020 and held it in 7 quarters.
  • Northwest & Ethical Investments's Burning Rock Biotech position peaked at $2.47M in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2022.

Based on Northwest & Ethical Investments's 13F filing for Q1 2022, filed 9 Jul 2025.